Get started
Author

Fatemeh Elahian

Observed names: Elahian Fatemeh, Fatemeh. Elahian
Observed institutions: Zanjan University of Medical Sciences, Mashhad University of Medical Sciences, Shahrekord University of Medical Sciences, Baylor College of Medicine, Texas Children's Hospital, Charité - Universitätsmedizin Berlin, University of Zanjan
ORCID: 0000-0002-1489-4047
Observed ORCIDs: 0000-0002-1489-4047, 0000-0002-1535-6240
OpenAlex ID: A5003458219
High-throughput bioaccumulation, biotransformation, and production of silver and selenium nanoparticles using genetically engineered Pichia pastoris
2016 · Fatemeh Elahian, Somayeh Reiisi, et al. · Nanomedicine Nanotechnology Biology and Medicine · 101
Human cytochrome b5 reductase: structure, function, and potential applications
2012 · Fatemeh Elahian, Zargham Sepehrizadeh, et al. · Critical Reviews in Biotechnology · 98
siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells
2021 · Razieh Heidari, Pegah Khosravian, et al. · Scientific Reports · 85
PDF
The Anticancer Agent Prodigiosin Is Not a Multidrug Resistance Protein Substrate
2013 · Fatemeh Elahian, Bahareh Moghimi, et al. · DNA and Cell Biology · 71
ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells
2017 · Seyed Abbas Mirzaei, Neda Gholamian Dehkordi, et al. · Toxicology and Applied Pharmacology · 41
Chitosan decorated cobalt zinc ferrite nanoferrofluid composites for potential cancer hyperthermia therapy: anti-cancer activity, genotoxicity, and immunotoxicity evaluation
2023 · Esmaeel Sharifi, Fatemeh Reisi, et al. · Advanced Composites and Hybrid Materials · 40
PDF
Engineered mesoporous silica nanoparticles, new insight nanoplatforms into effective cancer gene therapy
2023 · Razieh Heidari, Vahideh Assadollahi, et al. · International Journal of Biological Macromolecules · 37
Inflammatory pathway interactions and cancer multidrug resistance regulation
2019 · Seyed Abbas Mirzaei, Farideh Dinmohammadi, et al. · Life Sciences · 35
Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines
2010 · Fatemeh Kalalinia, Fatemeh Elahian, et al. · Journal of Cancer Research and Clinical Oncology · 34
Recent advances in mesoporous silica nanoparticles formulations and drug delivery for wound healing
2024 · Razieh Heidari, Vahideh Assadollahi, et al. · International Journal of Pharmaceutics · 30
Advances in skin gene therapy: utilizing innovative dressing scaffolds for wound healing, a comprehensive review
2024 · Fatemeh Karimzadeh, Elahe Soltani Fard, et al. · Journal of Materials Chemistry B · 28
Genetically modified Pichia pastoris , a powerful resistant factory for gold and palladium bioleaching and nanostructure heavy metal biosynthesis
2019 · Fatemeh Elahian, Razieh Heidari, et al. · Artificial Cells Nanomedicine and Biotechnology · 28
CRISPR/Cas9 as precision and high-throughput genetic engineering tools in gastrointestinal cancer research and therapy
2022 · Sayedeh Azimeh Hosseini, Alizamen Salehifard Jouneghani, et al. · International Journal of Biological Macromolecules · 27
Enzyme-sensitive nanoparticles, smart TAT and cetuximab conjugated immunoliposomes to overcome multidrug resistance in breast cancer cells
2022 · Mohsen Safaei, Pegah Khosravian, et al. · Toxicology and Applied Pharmacology · 26
Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell lines
2010 · Fatemeh Elahian, Fatemeh Kalalinia, et al. · Drug and Chemical Toxicology · 26
Dexamethasone Downregulates BCRP mRNA and Protein Expression in Breast Cancer Cell Lines
2009 · Fatemeh Elahian, Fatemeh Kalalinia, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 25
EXPRESSION OF CONCERN: Intelligent TAT‐coupled anti‐HER2 immunoliposomes knock downed MDR1 to produce chemosensitize phenotype of multidrug resistant carcinoma
2019 · Neda Gholamian Dehkordi, Fatemeh Elahian, et al. · Journal of Cellular Physiology · 22
Celecoxib Up Regulates the Expression of Drug Efflux Transporter ABCG2 in Breast Cancer Cell Lines.
2014 · Fatemeh Kalalinia, Fatemeh Elahian, et al. · PubMed · 19
Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectiveness
2020 · Neda Gholamian Dehkordi, Seyed Abbas Mirzaei, et al. · Inflammopharmacology · 17
Phorbol Ester TPA Modulates Chemoresistance in the Drug Sensitive Breast Cancer Cell Line MCF-7 by Inducing Expression of Drug Efflux Transporter ABCG2
2012 · Fatemeh Kalalinia, Fatemeh Elahian, et al. · Asian Pacific Journal of Cancer Prevention · 15
PDF
Synthesis and Anticancer Activity of 2,4,5-triaryl Imidazole Derivatives
2014 · Fatemeh Elahian, Morteza Akbari, et al. · Letters in Drug Design & Discovery · 12
The cell cycle arrest and the anti-invasive effects of nitrogen-containing bisphosphonates are not mediated by DBF4 in breast cancer cells
2013 · Mahdieh Mansouri, Seyed Abbas Mirzaei, et al. · Biochimie · 12
Silencing of α‐N‐acetylgalactosaminidase in the gastric cancer cells amplified cell death and attenuated migration, while the multidrug resistance remained unchanged
2021 · Mahbube Jafari, Nasibeh Rahimi, et al. · Cell Biology International · 10
DeeP4med: deep learning for P4 medicine to predict normal and cancer transcriptome in multiple human tissues
2023 · Roohallah Mahdi-Esferizi, Behnaz Haji Molla Hoseyni, et al. · BMC Bioinformatics · 8
PDF
Unlike Butylcycloheptylprodigiosin, Isolated Undecylprodigiosin from Streptomyces parvulus Is Not a MDR1 and BCRP Substrate in Multidrug-Resistant Cancers
2018 · Seyed Abbas Mirzaei, Mansureh Safari Kavishahi, et al. · DNA and Cell Biology · 7
Works count: 55
Citation count: 928
H-index: 18
I10-index: 23
Year
Topic
Type